date,title,source
Oct-24-18,VBI Vaccines to Present Initial Data for VBI-1901 in Recurrent Glioblastoma (GBM) Patients at the 2018 Annual Meeting of the Society for Neuro-Oncology (SNO),GlobeNewswire
Oct-25-18,"Research Report Identifies Sorrento Therapeutics, Hurco Companies, Veritiv, Park Electrochemical, VBI Vaccines, and PennantPark Floating Rate Capital with Renewed Outlook  Fundamental Analysis, Calculating Forward Movement",GlobeNewswire
Nov-09-18,VBI Vaccines Announces Third Quarter 2018 Financial Results and Provides Corporate Update,GlobeNewswire
Nov-16-18,"The Daily Biotech Pulse: Mallinckrodt FDA Verdict, European Cheer For Bristol-Myers Squibb, Morphosys Clinches Licensing Deal",Benzinga
Dec-06-18,VBI Vaccines Enters into License and Collaboration Agreement with Brii Biosciences for up to $129 Million plus Royalties to Develop a Functional Cure for Hepatitis B,GlobeNewswire
Dec-12-18,VBI Vaccines Announces Proposed Public Offering of Common Shares,GlobeNewswire
Dec-13-18,VBI Vaccines Announces Pricing of $37.5 Million Public Offering,GlobeNewswire
